Global Exome Sequencing Market to 2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 2, 2020--
The “Exome Sequencing Market” report has been added to ResearchAndMarkets.com’s offering.
The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing - despite price declines - has led to demands for more efficient methods.
Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual’s DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a person’s genome. Because most known mutations that cause disease occur in exons, whole-exome sequencing is thought to be an efficient method to identify possible disease-causing mutations.
The Exome Sequencing Market report provides the following data:
Key Topics Covered:
1: Executive Summary
2: Exome Sequencing Market
3: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/2ji5i2
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200102005328/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY GENETICS HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 01/02/2020 09:39 AM/DISC: 01/02/2020 09:39 AM